[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] ELEFTHERIADIS N.Definition and staging of early esophageal,gastric and colorectal cancer[J].J Tumor,2014,2(7):161-178.
[3] ONO H,KONDO H,GOTODA T,et al.Endoscopic mucosal resection for treatment of early gastric cancer[J].Gut,2001,48(2):225-229.
[4] ABDELFATAH M M,BARAKAT M,AHMAD D,et al.Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer:a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2019,31(4):418-424.
[5] TANABE S,HIRABAYASHI S,ODA I,et al.Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006:JGCA nationwide registry conducted in 2013[J].Gastric Cancer,2017,20(5):834-842.
[6] ONO H,YAO K,FUJISHIRO M,et al.Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer[J].Digest Endosc,2016,28(1):3-15.
[7] JEON M Y,PARK J C,HAHN K Y,et al.Long-term outcomes after noncurative endoscopic resection of early gastric cancer:the optimal time for additional endoscopic treatment[J].Gastrointest Endosc,2018,87(4):1003-1013.
[8] OHARA Y,TOSHIKUNI N,MATSUEDA K,et al.The superficial elevated and depressed lesion type is an independent factor associated with non-curative endoscopic submucosal dissection for early gastric cancer[J].Surg Endosc,2016,30(11):4880-4888.
[9] NAM H S,CHOI C W,KIM S J,et al.Preprocedural prediction of non-curative endoscopic submucosal dissection for early gastric cancer[J].PLoS One,2018,13(10):e0206179.
[10] HATTA W,GOTODA T,OYAMA T,et al.A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer:"eCura system"[J].Am J Gastroenterol,2017,112(6):874-881.
[11] HATTA W,GOTODA T,OYAMA T,et al.Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan[J].J Gastroenterol,2017,52(2):175-184.
[12] PARK J W,AHN S,LEE H,et al.Predictive factors for lymph node metastasis in early gastric cancer with lymphatic invasion after endoscopic resection[J].Surg Endosc,2017,31(11):4419-4424.
[13] JEON S W,PARK H W,KWON Y H,et al.Endoscopic indication of endoscopic submucosal dissection for early gastric cancer is not compatible with pathologic criteria in clinical practice[J].Digest Dis Sci,2019,64(2):373-381.
[14] INOKUCHI Y,KOBAYASHI M,KUDO K,et al.Outcomes and precautions of endoscopic submucosal dissection for undifferentiated-type early gastric cancer[J].Ther Adv Gastroenter,2015,8(5):255-262.
[15] KUMEI S,NAKAYAMA T,WATANABE T,et al.Impact of examining additional deeper sections on the pathological diagnosis of endoscopically resected early gastric cancer[J].Digest Endosc,2019,31(4):405-412.
[16] KIM E H,PARK J C,SONG I J,et al.Prediction model for non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer[J].Gastrointest Endosc,2017,85(5):976-983.
[17] ISOMOTO H.Differentiated-type predominant mixed-histology-type early gastric cancer is a significant risk factor for endoscopic non-curative resection regardless of tumor size[J].Dig Endosc,2018,30(5):602-604.
[18] HORIUCHI Y,FUJISAKI J,YAMAMOTO N,et al.Undifferentiated-type component mixed with differentiated-type early gastric cancer is a significant risk factor for endoscopic non-curative resection[J].Digest Endosc,2018,30(5):624-632.
[19] LEE S H,KIM M C,JEON S W,et al.Risk factors and clinical outcomes of non-curative resection in patients with early gastric cancer treated with endoscopic submucosal dissection:a retrospective multicenter study in Korea[J].Clin Endosc,2020,53(2):196-205.
[20] YOSHIMIZU S,YAMAMOTO Y,HORIUCHI Y,et al.A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer[J].Endosc Int Open,2019,7(2):E274-E281.
[21] PARK S W,LEE H,PARK C H,et al.Endoscopic and oncologic outcomes according to indication criteria of endoscopic resection for early gastric cancer:a systematic review and meta-analysis[J].Surg Endosc,2016,30(4):1270-1281.
[22] ZHAO Y,WANG C.Long-term clinical efficacy and perioperative safety of endoscopic submucosal dissection versus endoscopic mucosal resection for early gastric cancer:an updated meta-analysis[J].Biomed Res Int,2018:3152346.
[23] JUNG D H,LEE Y C,KIM J,et al.Additive treatment improves survival in elderly patients after non-curative endoscopic resection for early gastric cancer[J].Surg Endosc,2017,31(3):1376-1382.
[24] KIM H W,KIM J,PARK J C,et al.Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer[J].Gastrointest Endosc,2017,86(5):849-856.
[25] JEON M Y,PARK J C,HAHN K Y,et al.Long term outcomes after non-curative endoscopic resection of early gastric cancer according to the additional treatment[J].Gastrointest Endosc,2016,83S(5):B480-B481.
[26] LI D,LUAN H,WANG S,et al.Survival benefits of additional surgery after non-curative endoscopic resection in patients with early gastric cancer:a meta-analysis[J].Surg Endosc,2019,33(3):711-716.
[27] NIE R C,YUAN S Q,LI Y F,et al.Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection:a meta-analysis[J].Gastroenterol Rep,2019,7(2):91-97.
[28] ISHIDA R,KANAJI S,MAEHARA R,et al.Significance of additional gastrectomy including endoscopic submucosal dissection scar for gastric cancer[J].Anticancer Res,2018,38(9):5289-5294.
[29] SUNAGAWA H,KINOSHITA T,KAITO A,et al.Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer:a retrospective analysis of 200 cases[J].Surg Today,2017,47(2):202-209.
[30] SUZUKI H,ODA I,ABE S,et al.Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series[J].Gastric Cancer,2017,20(4):679-689.
[31] SEKIGUCHI M,SUZUKI H,ODA I,et al.Favorable long-term outcomes of endoscopic submucosal dissection for locally recurrent early gastric cancer after endoscopic resection[J].Endoscopy,2013,45(9):708-713.
[32] HWANG J J,PARK K J,PARK Y S,et al.A scoring system for patients with a tumor-positive lateral resection margin after endoscopic resection of early gastric cancer[J].Surg Endosc,2016,30(7):2751-2758.
[33] CHEN Y,ZHAO L,LIU L,et al.Optimal interval of additional endoscopic re-intervention for noncurative cases via endoscopic submucosal dissection[J].Gastrointest Endosc,2018,88(6):971-972.
[34] ZHAO B,ZHANG J,ZHANG J,et al.Risk factors associated with lymph node metastasis for early gastric cancer patients who underwent non-curative endoscopic resection:a systematic review and meta-analysis[J].J Gastrointest Surg,2019,23(7):1318-1328.
[35] SUZUKI H,ODA I,ABE S,et al.Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series[J].Gastric Cancer,2017,20(4):679-689.
[36] KAWATA N,KAKUSHIMA N,TAKIZAWA K,et al.Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection[J].Surg Endosc,2017,31(4):1607-1616.
[37] PYO J H,LEE H,MIN Y W,et al.Feasibility of endoscopic resection in early gastric cancer with lymphovascular invasion[J].Ann Surg Oncol,2019,26(2):449-455.
[38] TOYA Y,ENDO M,NAKAMURA S,et al.Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer[J].Gastrointest Endosc,2017,85(6):1218-1224.
[39] AKAIKE H,KAWAGUCHI Y,SHIRAISHI K,et al.Validity of additional surgical resection by comparing the operative risk with the stratified lymph node metastatic risk in patients with early gastric cancer after endoscopic submucosal dissection[J].World J Surg Oncol,2019,17(136):1-7.
[40] HATTA W,GOTODA T,OYAMA T,t al.Is additional surgery always sufficient for preventing recurrence after endoscopic submucosal dissection with curability C-2 for early gastric cancer?[J].Ann Surg Oncol,2019,26(11):3636-3643. |
